Literature DB >> 20089372

The positive allosteric modulator of the GABA(B) receptor, rac-BHFF, suppresses alcohol self-administration.

Paola Maccioni1, Andrew W Thomas, Mauro A M Carai, Gian Luigi Gessa, Pari Malherbe, Giancarlo Colombo.   

Abstract

The present study was designed to extend to the newly synthesized rac-BHFF [(R,S)-5,7-di-tert-butyl-3-hydroxy-3-trifluoromethyl-3H-benzofuran-2-one] the investigation on the capacity of positive allosteric modulators of the GABA(B) receptor to reduce alcohol self-administration in rats. To this end, selectively bred Sardinian alcohol-preferring (sP) rats were initially trained to respond on a lever [on a fixed ratio 4 (FR4) schedule of reinforcement] to orally self-administer alcohol (15%, v/v) or sucrose (0.7%, w/v) in daily 30-min sessions. Once responding reached stable levels, the effect of rac-BHFF (0, 50, 100, and 200mg/kg; i.g.) on responding for alcohol and sucrose was determined. Pretreatment with rac-BHFF produced a dose-dependent suppression in responding for alcohol; reduction in the total number of responses for alcohol, in comparison to vehicle-treated rats, averaged approximately 30%, 65%, and 90% in 50, 100, and 200mg/kg rac-BHFF-treated rats, respectively. Pretreatment with 200mg/kg rac-BHFF markedly increased the latency to the first response on the alcohol lever. The effect of pretreatment with rac-BHFF on alcohol self-administration was highly specific, since (a) responding for sucrose was reduced (to approximately 50%, in comparison to vehicle-treated rats) only by pretreatment with 200mg/kg rac-BHFF, and (b) latency to the first response on the sucrose lever was completely unaltered by any rac-BHFF dose. Treatment with rac-BHFF did not alter spontaneous locomotor activity in an independent group of sP rats. The present data constitute a further piece of evidence on the capacity of positive allosteric modulators of the GABA(B) receptor to reduce alcohol's reinforcing properties in rats. Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20089372     DOI: 10.1016/j.drugalcdep.2009.12.019

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  18 in total

Review 1.  Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future.

Authors:  Nazzareno Cannella; Massimo Ubaldi; Alessio Masi; Massimo Bramucci; Marisa Roberto; Angelo Bifone; Roberto Ciccocioppo
Journal:  Neurosci Biobehav Rev       Date:  2019-05-18       Impact factor: 8.989

Review 2.  Rat animal models for screening medications to treat alcohol use disorders.

Authors:  Richard L Bell; Sheketha R Hauser; Tiebing Liang; Youssef Sari; Antoniette Maldonado-Devincci; Zachary A Rodd
Journal:  Neuropharmacology       Date:  2017-02-16       Impact factor: 5.250

3.  Suppressing effect of COR659 on alcohol, sucrose, and chocolate self-administration in rats: involvement of the GABAB and cannabinoid CB1 receptors.

Authors:  Paola Maccioni; Giancarlo Colombo; Irene Lorrai; Alessandro Zaru; Mauro A M Carai; Gian Luigi Gessa; Antonella Brizzi; Claudia Mugnaini; Federico Corelli
Journal:  Psychopharmacology (Berl)       Date:  2017-05-24       Impact factor: 4.530

4.  Discriminative stimulus effects of the GABAB receptor-positive modulator rac-BHFF: comparison with GABAB receptor agonists and drugs of abuse.

Authors:  Wouter Koek; Kejun Cheng; Kenner C Rice
Journal:  J Pharmacol Exp Ther       Date:  2012-12-28       Impact factor: 4.030

5.  Alterations in the rate of binge ethanol consumption: implications for preclinical studies in mice.

Authors:  David N Linsenbardt; Stephen L Boehm
Journal:  Addict Biol       Date:  2013-03-13       Impact factor: 4.280

6.  Inhibition of alcohol self-administration by positive allosteric modulators of the GABAB receptor in rats: lack of tolerance and potentiation of baclofen.

Authors:  Paola Maccioni; Daniela Vargiolu; Andrew W Thomas; Pari Malherbe; Claudia Mugnaini; Federico Corelli; Kimberly A Leite-Morris; Gian Luigi Gessa; Giancarlo Colombo
Journal:  Psychopharmacology (Berl)       Date:  2014-11-26       Impact factor: 4.530

7.  Operant, oral alcoholic beer self-administration by C57BL/6J mice: effect of BHF177, a positive allosteric modulator of GABA(B) receptors.

Authors:  Alessandro Orrù; Daniele Fujani; Chiara Cassina; Mirko Conti; Angelo Di Clemente; Luigi Cervo
Journal:  Psychopharmacology (Berl)       Date:  2012-03-13       Impact factor: 4.530

8.  Comparison of the effect of the GABAΒ receptor agonist, baclofen, and the positive allosteric modulator of the GABAB receptor, GS39783, on alcohol self-administration in 3 different lines of alcohol-preferring rats.

Authors:  Paola Maccioni; Alessandro Zaru; Barbara Loi; Carla Lobina; Mauro A M Carai; Gian Luigi Gessa; Alessandro Capra; Claudia Mugnaini; Serena Pasquini; Federico Corelli; Petri Hyytiä; Lawrence Lumeng; Giancarlo Colombo
Journal:  Alcohol Clin Exp Res       Date:  2012-04-06       Impact factor: 3.455

Review 9.  Potential of GABAB Receptor Positive Allosteric Modulators in the Treatment of Alcohol Use Disorder.

Authors:  Paola Maccioni; Giancarlo Colombo
Journal:  CNS Drugs       Date:  2019-02       Impact factor: 5.749

Review 10.  Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity.

Authors:  Richard L Bell; Helen J K Sable; Giancarlo Colombo; Petri Hyytia; Zachary A Rodd; Lawrence Lumeng
Journal:  Pharmacol Biochem Behav       Date:  2012-07-25       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.